Optimization and validation of an angiotensin-converting enzyme
inhibition assay for the screening of bioactive peptides.
Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin-converting enzyme
inhibitor therapy in patients with heart failure: Vasodilator Heart Failure Trial (V-HeFT) Study Group.
I/D polymorphism of the angiotensin-converting enzyme
gene does not predict isolated systolic or systolic-dias tolic hypertension in the elderly.
PCR detection of the insertion/ deletion polymorphism of the human angiotensin-converting enzyme
gene (DCP 1) (dipeptidyl carboxypeptidase 1).
Presumably because angiotensin-converting enzyme
inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including PRINIVIL) may be subject to a variety of adverse reactions, some of them serious.
An angiotensin-converting enzyme
inhibitor--essential for renal protection in any antihypertensive regimen for patients with diabetes or renal disease--can be obtained for less than a dime per day with a prescription for a year's supply of generic captopril, Dr.
inhibitors are vasodilators, drugs which widen blood vessels, making it easier for a weakened heart to pump blood.
Those drugs include angiotensin-converting enzyme
(ACE) inhibitors, which are currently being used to treat heart failure after it develops.
MANOPLAX, a convenient once-daily tablet, is indicated for the management of congestive heart failure in patients not responding adequately to diuretics (with or without digitalis) who either cannot tolerate an angiotensin-converting enzyme
(ACE) inhibitor or who have not responded adequately to a regimen including an ACE inhibitor.
The communications program draws additional attention within the healthcare community to existing warnings in the prescribing information for angiotensin-converting enzyme
The patients were randomized to also receive 10-40 mg daily of the angiotensin-converting enzyme
(ACE) inhibitor lisinopril or placebo.
gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura.